CAS 1030633-38-5
:Etravirine hydrobromide
Description:
Etravirine hydrobromide is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used primarily in the treatment of HIV-1 infection. It is characterized by its ability to inhibit the reverse transcriptase enzyme, which is crucial for the replication of the virus. Etravirine is known for its efficacy against HIV strains that are resistant to other NNRTIs, making it a valuable option in antiretroviral therapy. The hydrobromide salt form enhances its solubility and stability, facilitating its use in pharmaceutical formulations. Chemically, Etravirine features a complex structure with multiple functional groups, contributing to its pharmacological properties. It is typically administered orally and is often part of a combination therapy regimen to improve treatment outcomes. The substance is generally well-tolerated, though it may have side effects, including rash and gastrointestinal disturbances. As with all antiretroviral medications, monitoring for drug interactions and resistance patterns is essential for effective treatment management.
Formula:C20H16Br2N6O
Synonyms:- Etravirine hydrobromide
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.
